Merck KGaA owns the rights to the name "Merck" in 191 of 193 countries.
Merck is a German multinational pharmaceutical, chemical and life sciences company headquartered in Darmstadt, with ~250 companies operating in ~180 countries. Merck operates in the USA (23.6%); Europe (23.1%), China (10.3%); Africa (4%); Asia/Pacific (21.8%); Latin America (8%). Merck operates through the following sectors:
- 45.7%: Pharmaceutical products: prescribed medicines (treatment of diabetes, cardiovascular diseases, central nervous system disorders and hormonal disorders), nutritional supplements and OTC medicines;
- 38.4%: Biotechnological products (38.4%);
- 15.9%: Chemical products: reagents and laboratory chemicals, pigments and liquid crystals.
E Merck KG does not participate in the management of the company; it makes the fundamental entrepreneurial decisions of the Merck Group. The Merck Family holds 99.9% of the capital of E Merck KG; the remainder is held by the members of the Executive Board of Merck KGaA.ref
- 70.3% Merck family
- 4.91% Massachusetts Financial Services Company
- 3.12% Crédit Agricole SA § Amundi Asset Management SA
- 3.00% Vanguard Group Inc
- 2.59% McKinley Capital Management LLC
- 2.54% Deutsche Bank AG#DWS Investments (UK) Ltd
- 2.21% Norges Bank Investment Management
- 1.90% Templeton Global Advisors Ltd
- 1.58% Capital Research & Management Company (World)
- 1.26% Union Investment Privatfonds GmbH
- 1.22% Thornburg Investment Management Inc
- Dec.15.2018: Merck pays £1.9bn for pet tagger. Keeping track of pets and farm livestock is a growing £multi-billion business. Yesterday Merck, the US healthcare company, announced that it had paid £1.9 billion for the privately held French company Antelliq, which makes identification products for livestock, to bolster its fast-growing animal health business. Antelliq provides vets, farmers and pet owners with digital technology that monitors animals and predicts disease. Real-time information helps to improve livestock management and health. In the financial year to the end of September these products brought in sales worth €360 million. The Times, Robert Miller.
- Apr.20.2018: Merck’s big health brands snapped up by Procter & Gamble. Merck has become the latest drug company to offload its consumer healthcare business, selling the division that makes Seven Seas cod liver oil for €3.4bn. The proposed deal with Procter & Gamble would allow Merck to focus on its core healthcare and life sciences business. Merck’s consumer health unit makes 900 over-the-counter health products for sale in 44 countries. P&G, which makes Gillette razors and Pampers nappies, is the world’s largest consumer goods maker. It has been facing a slowdown in demand for big-brand products as consumers shift to local and independent labels. It has also been under pressure to improve margins from an activist hedge fund. The Times, James Dean.